lifestyle.californiaconsumerbanking.com

Author: Boehringer Ingelheim Limited

Boehringer Ingelheim delivers on late-stage pipeline with two key launches, grows sales by 7.3%* in a successful 2025

May 4, 2026
Boehringer Ingelheim and Connecticut Science Center Launch an Innovation Lab to Advance STEM Education Across Connecticut

May 3, 2026
Global survey reveals pet owners lack awareness of parasite risks and seek clearer prevention advice

May 2, 2026
Boehringer Ingelheim Granted Emergency Use Authorization for New World Screwworm Treatments in Dogs and Cats

March 11, 2026
Boehringer Ingelheim Secures Emergency Use Authorization for IVOMEC® (ivermectin) 1% Injection to Help Protect Cattle Against New World Screwworm

March 9, 2026
Boehringer Ingelheim’s investigational asset apecotrep delivers proteinuria reduction in Phase II kidney trial

January 28, 2026
Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease

January 27, 2026